Molecular Typing and Resistance Profiles of Vancomycin-Intermediate Staphylococcus aureus in Korea: Results from a National Surveillance Study, 2007-2013
Background: To investigate the national molecular epidemiology and resistance profiles of vancomycinintermediate Staphylococcus aureus (VISA), we analyzed the characteristics of methicillin-resistant Staphylococcus aureus (MRSA) collected from clinical samples at tertiary or general hospitals partic...
Saved in:
| Published in | Annals of clinical microbiology Vol. 19; no. 4; pp. 88 - 96 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
대한임상미생물학회
01.12.2016
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 2288-0585 2288-0585 2288-6850 |
| DOI | 10.5145/ACM.2016.19.4.88 |
Cover
| Abstract | Background: To investigate the national molecular epidemiology and resistance profiles of vancomycinintermediate Staphylococcus aureus (VISA), we analyzed the characteristics of methicillin-resistant Staphylococcus aureus (MRSA) collected from clinical samples at tertiary or general hospitals participating in a nationwide surveillance program for VISA and vancomycin-resistant Staphylococcus aureus (VRSA) in Korea during an 12-week period in each year from 2007 to 2013.
Methods: VISA was defined by agar dilution, broth dilution and E-test methods with vancomycin minimum inhibitory concentrations of >2 μg/mL. All VISA isolates were characterized by multilocus sequence typing, staphylococcal cassette chromosome mec typing, spa typing, accessory gene regulator typing, Diversilab analysis, and antibiogram analysis.
Results: Of 109,345 MRSA isolates, 87,354 were screened and 426 isolates were identified as positive on brain heart infusion agar containing 4 μg/mL vancomycin (BHI-V4). Of 426 isolates, 76 isolates were identified as VISA. No VRSA isolates were detected among the isolates. Overall, a total of 6 genotypes were identified among VISA strains and the predominant clones were ST5-II-t2460, ST72-IV-t324, and ST239-III-t037 (44.7%, 15.8%, and 10.5%, respectively). Of note, ST72-IV-t324 clones are known to be a typical community-associated MRSA. ST239-IIIt037 strains were more resistant to trimethoprim-sulfamethoxazole than any other type of strain. ST72- IV-t324 strains were susceptible to all of the antimicrobial agents tested except erythromycin and daptomycin. All of the VISA isolates were susceptible to linezolid and quinupristin-dalfopristin.
Conclusion: Although VRSA is still rare, continuous monitoring of VRSA occurrence is needed, as well as VISA prevalence, epidemic clonal shift, and antimicrobial resistance. KCI Citation Count: 0 |
|---|---|
| AbstractList | Background: To investigate the national molecular epidemiology and resistance profiles of vancomycinintermediate Staphylococcus aureus (VISA), we analyzed the characteristics of methicillin-resistant Staphylococcus aureus (MRSA) collected from clinical samples at tertiary or general hospitals participating in a nationwide surveillance program for VISA and vancomycin-resistant Staphylococcus aureus (VRSA) in Korea during an 12-week period in each year from 2007 to 2013.
Methods: VISA was defined by agar dilution, broth dilution and E-test methods with vancomycin minimum inhibitory concentrations of >2 μg/mL. All VISA isolates were characterized by multilocus sequence typing, staphylococcal cassette chromosome mec typing, spa typing, accessory gene regulator typing, Diversilab analysis, and antibiogram analysis.
Results: Of 109,345 MRSA isolates, 87,354 were screened and 426 isolates were identified as positive on brain heart infusion agar containing 4 μg/mL vancomycin (BHI-V4). Of 426 isolates, 76 isolates were identified as VISA. No VRSA isolates were detected among the isolates. Overall, a total of 6 genotypes were identified among VISA strains and the predominant clones were ST5-II-t2460, ST72-IV-t324, and ST239-III-t037 (44.7%, 15.8%, and 10.5%, respectively). Of note, ST72-IV-t324 clones are known to be a typical community-associated MRSA. ST239-IIIt037 strains were more resistant to trimethoprim-sulfamethoxazole than any other type of strain. ST72- IV-t324 strains were susceptible to all of the antimicrobial agents tested except erythromycin and daptomycin. All of the VISA isolates were susceptible to linezolid and quinupristin-dalfopristin.
Conclusion: Although VRSA is still rare, continuous monitoring of VRSA occurrence is needed, as well as VISA prevalence, epidemic clonal shift, and antimicrobial resistance. KCI Citation Count: 0 |
| Author | Lee, Kwang-Jun Kang, Gi Su Kim, Il-Hwan Kim, Hwa Su Yu, Jae-Yon Park, Chan Kim, Jung Wook Lee, Yeong Seon Yoo, Jae Il |
| Author_xml | – sequence: 1 givenname: Jung Wook surname: Kim fullname: Kim, Jung Wook organization: Division of Antimicrobial Resistance, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju, Korea – sequence: 2 givenname: Gi Su surname: Kang fullname: Kang, Gi Su organization: Division of Antimicrobial Resistance, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju, Korea – sequence: 3 givenname: Jae Il surname: Yoo fullname: Yoo, Jae Il organization: Division of Antimicrobial Resistance, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju, Korea – sequence: 4 givenname: Hwa Su surname: Kim fullname: Kim, Hwa Su organization: Division of Antimicrobial Resistance, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju, Korea – sequence: 5 givenname: Yeong Seon surname: Lee fullname: Lee, Yeong Seon organization: Division of Antimicrobial Resistance, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju, Korea – sequence: 6 givenname: Jae-Yon surname: Yu fullname: Yu, Jae-Yon organization: Division of Antimicrobial Resistance, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju, Korea – sequence: 7 givenname: Kwang-Jun surname: Lee fullname: Lee, Kwang-Jun organization: Division of Antimicrobial Resistance, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju, Korea – sequence: 8 givenname: Chan surname: Park fullname: Park, Chan organization: Division of Antimicrobial Resistance, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju, Korea – sequence: 9 givenname: Il-Hwan surname: Kim fullname: Kim, Il-Hwan organization: Division of Antimicrobial Resistance, Korea National Research Institute of Health, Korea Centers for Disease Control and Prevention, Cheongju, Korea |
| BackLink | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002173920$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNp1UU1vEzEUtFCRWkrvPfqKxG6fvV82tyiiENHSqglcrRevt5g6dmR7kfan8G-7STkgJN5lnp5m5mk0b8iJD94QcsmgbFjdXC2WtyUH1pZMlnUpxCtyxrkQBTSiOflrPyUXKf2EeWQHXLZn5PdtcEaPDiPdTHvrHyn6nj6YZFNGrw29j2GwziQaBvp9voTdpK0vVj6buDO9xWzoOuP-x-SCDlqPieIYzQzW0y8hGvxwsBtdTnSIYUeRfsVsg0dH12P8Zaxzx0frPPbTe8oBumLOUr0lrwd0yVz8wXPy7frjZvm5uLn7tFoubgrNOJdFswXo6xql6IB1221loDO6A80QBmj7GvoWhdxy3jSmEhLaRlZodM_6jqGoq3Py7sXXx0E9aasC2iM-BvUU1eJhs1KMS84qOXPbF66OIaVoBqVtPqbJEa1TDNShDzX3oQ59KCZVrYSYhfCPcB_tDuP0f8kzswKPog |
| CitedBy_id | crossref_primary_10_1089_mdr_2020_0346 crossref_primary_10_1089_mdr_2018_0069 crossref_primary_10_3390_pathogens10050564 crossref_primary_10_1016_j_jgar_2018_06_018 |
| Cites_doi | 10.1016/j.ijantimicag.2010.06.044 10.1371/journal.pone.0073300 10.1016/j.meegid.2013.03.047 10.1093/jac/40.1.135 10.1093/jac/47.4.399 10.1128/AAC.46.7.2155-2161.2002 10.5402/2012/215275 10.1128/AAC.47.10.3040-3045.2003 10.1371/journal.pone.0136082 10.1128/JCM.38.3.1008-1015.2000 10.1093/jac/dkq009 10.1093/jac/dki413 10.1086/513203 10.1016/S1473-3099(13)70136-1 10.1128/JCM.01152-11 10.1016/S0140-6736(13)61219-2 10.1128/JCM.41.12.5442-5448.2003 10.1016/j.ijantimicag.2013.06.004 10.1128/AAC.00904-08 10.1128/AAC.00093-09 10.1128/AAC.00206-09 10.1128/JCM.00582-08 10.1128/JCM.40.11.4060-4067.2002 10.1007/s12275-016-6157-x 10.1128/JCM.42.2.792-799.2004 10.1128/AAC.01316-09 10.1016/S0140-6736(09)61999-1 10.1093/cid/cir935 10.1086/593953 10.1016/j.ijantimicag.2015.03.009 10.1128/JCM.43.3.1187-1192.2005 10.15585/mmwr.mm6437a6 |
| ContentType | Journal Article |
| DBID | AAYXX CITATION ACYCR |
| DOI | 10.5145/ACM.2016.19.4.88 |
| DatabaseName | CrossRef Korean Citation Index |
| DatabaseTitle | CrossRef |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2288-0585 2288-6850 |
| EndPage | 96 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_1292139 10_5145_ACM_2016_19_4_88 |
| GroupedDBID | 5-W 8JR 8XY AAYXX ACYCR ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL CITATION DIK EF. GROUPED_DOAJ |
| ID | FETCH-LOGICAL-c1229-5b00d44a987017bb3e07ec70c1a0f06d40d6a89b2255e38906593aecd1d71a843 |
| ISSN | 2288-0585 |
| IngestDate | Sun Feb 18 03:18:22 EST 2024 Tue Jul 01 04:13:48 EDT 2025 Thu Apr 24 23:10:53 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc/4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c1229-5b00d44a987017bb3e07ec70c1a0f06d40d6a89b2255e38906593aecd1d71a843 |
| Notes | G704-001687.2016.19.4.002 |
| PageCount | 9 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_1292139 crossref_citationtrail_10_5145_ACM_2016_19_4_88 crossref_primary_10_5145_ACM_2016_19_4_88 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2016-12 |
| PublicationDateYYYYMMDD | 2016-12-01 |
| PublicationDate_xml | – month: 12 year: 2016 text: 2016-12 |
| PublicationDecade | 2010 |
| PublicationTitle | Annals of clinical microbiology |
| PublicationYear | 2016 |
| Publisher | 대한임상미생물학회 |
| Publisher_xml | – name: 대한임상미생물학회 |
| References | Joo (10.5145/ACM.2016.19.4.88_ref32) 2016; 54 Rybak (10.5145/ACM.2016.19.4.88_ref4) 2008; 46 Melo-Cristino (10.5145/ACM.2016.19.4.88_ref12) 2013; 382 Wootton (10.5145/ACM.2016.19.4.88_ref8) 2001; 47 Adam (10.5145/ACM.2016.19.4.88_ref5) 2010; 54 Howden (10.5145/ACM.2016.19.4.88_ref1) 2014; 21 van Hal (10.5145/ACM.2016.19.4.88_ref16) 2012; 54 Garnier (10.5145/ACM.2016.19.4.88_ref10) 2006; 57 Havaei (10.5145/ACM.2016.19.4.88_ref28) 2012; 2012 Chuang (10.5145/ACM.2016.19.4.88_ref30) 2013; 13 Gilot (10.5145/ACM.2016.19.4.88_ref22) 2002; 40 Tenover (10.5145/ACM.2016.19.4.88_ref15) 2007; 44 Hu (10.5145/ACM.2016.19.4.88_ref26) 2013; 8 Harmsen (10.5145/ACM.2016.19.4.88_ref19) 2003; 41 Zhang (10.5145/ACM.2016.19.4.88_ref25) 2015; 10 Walters (10.5145/ACM.2016.19.4.88_ref14) 2015; 64 Koreen (10.5145/ACM.2016.19.4.88_ref20) 2004; 42 DeLeo (10.5145/ACM.2016.19.4.88_ref29) 2010; 375 Sader (10.5145/ACM.2016.19.4.88_ref34) 2009; 53 Richter (10.5145/ACM.2016.19.4.88_ref3) 2011; 49 Oliveira (10.5145/ACM.2016.19.4.88_ref21) 2002; 46 Park (10.5145/ACM.2016.19.4.88_ref31) 2009; 30 Kirby (10.5145/ACM.2016.19.4.88_ref7) 2010; 65 Liu (10.5145/ACM.2016.19.4.88_ref27) 2003; 47 Sun (10.5145/ACM.2016.19.4.88_ref6) 2009; 53 Shutt (10.5145/ACM.2016.19.4.88_ref23) 2005; 43 Bartley (10.5145/ACM.2016.19.4.88_ref11) 2002; 23 Hiramatsu (10.5145/ACM.2016.19.4.88_ref2) 1997; 40 Enright (10.5145/ACM.2016.19.4.88_ref18) 2000; 38 Chung (10.5145/ACM.2016.19.4.88_ref24) 2015; 46 Moravvej (10.5145/ACM.2016.19.4.88_ref13) 2013; 42 Chung (10.5145/ACM.2016.19.4.88_ref17) 2010; 20 Campanile (10.5145/ACM.2016.19.4.88_ref9) 2010; 36 Prakash (10.5145/ACM.2016.19.4.88_ref33) 2008; 52 |
| References_xml | – volume: 36 start-page: 415 year: 2010 ident: 10.5145/ACM.2016.19.4.88_ref9 publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2010.06.044 – volume: 8 start-page: e73300 year: 2013 ident: 10.5145/ACM.2016.19.4.88_ref26 publication-title: PLoS One doi: 10.1371/journal.pone.0073300 – volume: 21 start-page: 575 year: 2014 ident: 10.5145/ACM.2016.19.4.88_ref1 publication-title: Infect Genet Evol doi: 10.1016/j.meegid.2013.03.047 – volume: 40 start-page: 135 year: 1997 ident: 10.5145/ACM.2016.19.4.88_ref2 publication-title: J Antimicrob Chemother doi: 10.1093/jac/40.1.135 – volume: 47 start-page: 399 year: 2001 ident: 10.5145/ACM.2016.19.4.88_ref8 publication-title: J Antimicrob Chemother doi: 10.1093/jac/47.4.399 – volume: 46 start-page: 2155 year: 2002 ident: 10.5145/ACM.2016.19.4.88_ref21 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.46.7.2155-2161.2002 – volume: 2012 start-page: 215275 year: 2012 ident: 10.5145/ACM.2016.19.4.88_ref28 publication-title: ISRN Microbiol doi: 10.5402/2012/215275 – volume: 20 start-page: 637 year: 2010 ident: 10.5145/ACM.2016.19.4.88_ref17 publication-title: J Microbiol Biotechnol – volume: 47 start-page: 3040 year: 2003 ident: 10.5145/ACM.2016.19.4.88_ref27 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.47.10.3040-3045.2003 – volume: 10 start-page: e0136082 year: 2015 ident: 10.5145/ACM.2016.19.4.88_ref25 publication-title: PLoS One doi: 10.1371/journal.pone.0136082 – volume: 38 start-page: 1008 year: 2000 ident: 10.5145/ACM.2016.19.4.88_ref18 publication-title: J Clin Microbiol doi: 10.1128/JCM.38.3.1008-1015.2000 – volume: 65 start-page: 721 year: 2010 ident: 10.5145/ACM.2016.19.4.88_ref7 publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkq009 – volume: 57 start-page: 146 year: 2006 ident: 10.5145/ACM.2016.19.4.88_ref10 publication-title: J Antimicrob Chemother doi: 10.1093/jac/dki413 – volume: 44 start-page: 1208 year: 2007 ident: 10.5145/ACM.2016.19.4.88_ref15 publication-title: Clin Infect Dis doi: 10.1086/513203 – volume: 13 start-page: 698 year: 2013 ident: 10.5145/ACM.2016.19.4.88_ref30 publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(13)70136-1 – volume: 49 start-page: 4203 year: 2011 ident: 10.5145/ACM.2016.19.4.88_ref3 publication-title: J Clin Microbiol doi: 10.1128/JCM.01152-11 – volume: 23 start-page: 480 year: 2002 ident: 10.5145/ACM.2016.19.4.88_ref11 publication-title: Infect Control Hosp Epidemiol – volume: 382 start-page: 205 year: 2013 ident: 10.5145/ACM.2016.19.4.88_ref12 publication-title: Lancet doi: 10.1016/S0140-6736(13)61219-2 – volume: 41 start-page: 5442 year: 2003 ident: 10.5145/ACM.2016.19.4.88_ref19 publication-title: J Clin Microbiol doi: 10.1128/JCM.41.12.5442-5448.2003 – volume: 42 start-page: 370 year: 2013 ident: 10.5145/ACM.2016.19.4.88_ref13 publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2013.06.004 – volume: 52 start-page: 4528 year: 2008 ident: 10.5145/ACM.2016.19.4.88_ref33 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00904-08 – volume: 53 start-page: 3162 year: 2009 ident: 10.5145/ACM.2016.19.4.88_ref34 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00093-09 – volume: 53 start-page: 3642 year: 2009 ident: 10.5145/ACM.2016.19.4.88_ref6 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00206-09 – volume: 46 start-page: 2950 year: 2008 ident: 10.5145/ACM.2016.19.4.88_ref4 publication-title: J Clin Microbiol doi: 10.1128/JCM.00582-08 – volume: 40 start-page: 4060 year: 2002 ident: 10.5145/ACM.2016.19.4.88_ref22 publication-title: J Clin Microbiol doi: 10.1128/JCM.40.11.4060-4067.2002 – volume: 54 start-page: 445 year: 2016 ident: 10.5145/ACM.2016.19.4.88_ref32 publication-title: J Microbiol doi: 10.1007/s12275-016-6157-x – volume: 42 start-page: 792 year: 2004 ident: 10.5145/ACM.2016.19.4.88_ref20 publication-title: J Clin Microbiol doi: 10.1128/JCM.42.2.792-799.2004 – volume: 54 start-page: 945 year: 2010 ident: 10.5145/ACM.2016.19.4.88_ref5 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01316-09 – volume: 375 start-page: 1557 year: 2010 ident: 10.5145/ACM.2016.19.4.88_ref29 publication-title: Lancet doi: 10.1016/S0140-6736(09)61999-1 – volume: 54 start-page: 755 year: 2012 ident: 10.5145/ACM.2016.19.4.88_ref16 publication-title: Clin Infect Dis doi: 10.1093/cid/cir935 – volume: 30 start-page: 146 year: 2009 ident: 10.5145/ACM.2016.19.4.88_ref31 publication-title: Infect Control Hosp Epidemiol doi: 10.1086/593953 – volume: 46 start-page: 338 year: 2015 ident: 10.5145/ACM.2016.19.4.88_ref24 publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2015.03.009 – volume: 43 start-page: 1187 year: 2005 ident: 10.5145/ACM.2016.19.4.88_ref23 publication-title: J Clin Microbiol doi: 10.1128/JCM.43.3.1187-1192.2005 – volume: 64 start-page: 1056 year: 2015 ident: 10.5145/ACM.2016.19.4.88_ref14 publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm6437a6 |
| SSID | ssj0000970296 |
| Score | 1.9729111 |
| Snippet | Background: To investigate the national molecular epidemiology and resistance profiles of vancomycinintermediate Staphylococcus aureus (VISA), we analyzed the... |
| SourceID | nrf crossref |
| SourceType | Open Website Enrichment Source Index Database |
| StartPage | 88 |
| SubjectTerms | 임상병리학 |
| Title | Molecular Typing and Resistance Profiles of Vancomycin-Intermediate Staphylococcus aureus in Korea: Results from a National Surveillance Study, 2007-2013 |
| URI | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002173920 |
| Volume | 19 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Annals of Clinical Microbiology, 2016, 19(4), 19, pp.88-96 |
| journalDatabaseRights | – providerCode: PRVAON databaseName: Openly Available Collection - DOAJ customDbUrl: eissn: 2288-0585 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000970296 issn: 2288-0585 databaseCode: DOA dateStart: 19980101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2288-0585 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000970296 issn: 2288-0585 databaseCode: DIK dateStart: 20130101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVERR databaseName: KoreaMed Open Access customDbUrl: eissn: 2288-0585 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000970296 issn: 2288-0585 databaseCode: 5-W dateStart: 20130101 isFulltext: true titleUrlDefault: https://koreamed.org/journals providerName: Korean Association of Medical Journal Editors |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF615cIFgQBRXlohfEDBqR9re5eb46YqoFRItKg3a22vq6itjZIYCf4J_5aZXTt2ohYVLtZosg8n32fP7GZ2hpC3mWJFGajQBlumbMac3OZlFtheIcPCyXxR6GjC2Ul4fMY-nQfnO7vxIGqpWWXj_NeN50r-B1XQAa54SvYfkF0PCgqQAV-4AsJwvRPGs6627QiWk_1pwyX6hPjAfjEFuXW0xjfQ1Nc_83ll611AfWRkhYGEmLEaTFqd581yJJuFanSM7Oca_EkTL7dsrlZLcxJFjk667cOvzeKHwqJFOpsnpqlFvPSuJNh7f-j29mma1ycxr-d9CqgOdWsaWxOBwRfTxIodSwQoCFC6G03MJyBwlKEJ55bgfRPoo_ujMLXiRAuH1iS5YaJDSwhLsM1R2m0QN9wKKbGmE4snXb8ApzFzcDOAD445tomP8N6MBiZGTQLTd72EFmIYqn8Pex7QzglMZaGx6nUhNzlz23e_KU_YehGmTO-2fQLvFFN5xMkMgwrDsSvGbNz1G6YC3zLRG8nAL_N5elGnl4sUljwfU3DYPHDjd8k9DwybM9hV0M6IiBxPV6lbfw3zZz3eysH2jWw4Z7vVohz4WqcPyYN2kURjw_hHZEdVj8nvNdupYTsFttOe7bRjO61Legvb6SbbqWE7nVdUs_0DbblOketU0o7rdMh1qrn-nq6Z_oScHU1Pk2O7LSxi567nCTsAW1MwJgUYKzfKMl85kcojJ3elUzphwZwilFxkYOsCBR49xh74UuWFW0Su5Mx_SvaqulLPCI14yfxIZiFTJYskkwBHoUpYssIrumRqnxx0v2iat1n3sfjLVQqrb8QgBQxSxCB1RcpSzvfJu3WP7ybjzF_avgGQNCNuZ8bzuzR6Qe73T9VLsrdaNOoVuNur7LUm1B8Rlr8j |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Molecular+Typing+and+Resistance+Profiles+of+Vancomycin-Intermediate+Staphylococcus+aureus+in+Korea%3A+Results+from+a+National+Surveillance+Study%2C+2007-2013&rft.jtitle=Annals+of+clinical+microbiology&rft.au=%EA%B9%80%EC%A0%95%EC%9A%B1&rft.au=%EA%B0%95%EA%B8%B0%EC%88%98&rft.au=%EC%9C%A0%EC%9E%AC%EC%9D%BC&rft.au=%EA%B9%80%ED%99%94%EC%88%98&rft.date=2016-12-01&rft.pub=%EB%8C%80%ED%95%9C%EC%9E%84%EC%83%81%EB%AF%B8%EC%83%9D%EB%AC%BC%ED%95%99%ED%9A%8C&rft.issn=2288-0585&rft.eissn=2288-6850&rft.spage=88&rft.epage=96&rft_id=info:doi/10.5145%2FACM.2016.19.4.88&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_1292139 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2288-0585&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2288-0585&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2288-0585&client=summon |